Recombinant Acinetobacter sp. 50S ribosomal protein L16 (rplP)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Acinetobacter sp. 50S Ribosomal Protein L16 (rplP)

Recombinant Acinetobacter sp. 50S ribosomal protein L16 (rplP) is a synthesized protein derived from Acinetobacter species, mirroring the naturally occurring 50S ribosomal protein L16 . Ribosomal proteins, like L16, are essential components of ribosomes, which are responsible for protein synthesis in cells . The "50S" refers to the larger subunit of the bacterial ribosome, and L16 is one of the many proteins that constitute this subunit.

The recombinant form of this protein is produced using genetic engineering techniques, typically in a host organism like Escherichia coli, to generate large quantities of the protein for research or other applications . The rplP gene encodes the ribosomal protein L16 .

Characteristics

CharacteristicDescription
Source OrganismAcinetobacter species (e.g., Acinetobacter baumannii)
Protein Type50S ribosomal protein L16 (rplP)
Production MethodRecombinant expression, often in E. coli
PurityTypically >85% (SDS-PAGE)
Amino Acid Sequencevaries based on species. For example, Acinetobacter baumannii: MLQPKRTKFR KVHKGRNTGL AHRGSTVSFG SIAIKATERG RMTARQIEAA RRTISRRIKR GGKIFIRVFP DKPITEKPLE VRMGNGKGNV EYWVCEIKPG KILYEIEGVN EDLAREAFAL AAAKLPFKTT IVTRTVM
Molecular WeightApproximately 16-18 kDa (estimated)
StorageLiquid form: 6 months at -20°C/-80°C; Lyophilized form: 12 months at -20°C/-80°C
FunctionPart of the 50S ribosomal subunit, crucial for protein synthesis
Expression RegionFull length protein, typically 1-137 amino acids

Function and Role

The primary function of the 50S ribosomal protein L16 is its involvement in protein synthesis . Ribosomes, composed of 30S and 50S subunits in bacteria, are the sites where mRNA is translated into proteins. L16, as a component of the 50S subunit, plays a critical role in the structural integrity and functional activity of the ribosome.

Research Applications

  1. Antimicrobial Discovery: Ribosomal proteins are increasingly studied as potential targets for new antimicrobials . The rationale is that by disrupting the bacterial ribosome's function, it's possible to inhibit protein synthesis and, thus, bacterial growth.

  2. Resistance Mechanisms: Research indicates that the expression of ribosomal proteins, including L16, can be altered in response to antibiotic exposure . For example, increased expression of ribosomal proteins has been observed in Acinetobacter strains that have developed resistance to antibiotics like eravacycline.

  3. Basic Research: Recombinant L16 is used in structural and functional studies of ribosomes . These studies aim to elucidate the precise mechanisms of protein synthesis and how ribosomes interact with various factors and antibiotics.

  4. Vaccine Development: Ribosomal proteins have been explored as potential vaccine candidates . Their conserved nature and essential function make them attractive targets for eliciting broad-spectrum immunity.

Role in Antibiotic Resistance

The up-regulation of ribosomal proteins is associated with antibiotic resistance in Acinetobacter strains . In Acinetobacter strains resistant to eravacycline, experiments have revealed increased expression of ribosomal proteins. This suggests that changes in ribosomal protein expression can be a mechanism by which bacteria adapt and survive in the presence of antibiotics.

Methodologies for Studying rplP

  • Gene Sequencing: Utilizing techniques like 16S rRNA sequencing to identify and differentiate closely related bacterial species, which is crucial in studies involving Acinetobacter .

  • Proteomic Analysis: Employing mass spectrometry to quantify protein levels in mutant strains, which helps in understanding the impact of metabolic disruptions on ribosomal protein levels .

  • Heterologous Expression: Refactoring biosynthetic gene clusters in organisms like E. coli to produce and study modified peptides and their antimicrobial activities .

  • qRT-PCR Analysis: Quantifying gene expression changes in response to antibiotic induction, providing insights into resistance mechanisms .

  • In silico structural modeling: predicting protein structure and function through computational methods based on sequence data.

Product Specs

Form
Lyophilized powder.
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Consult your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a reference.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during the manufacturing process.
If a specific tag type is required, please inform us; we will prioritize its development.
Synonyms
rplP; ACIAD3212; 50S ribosomal protein L16
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-137
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Acinetobacter baylyi (strain ATCC 33305 / BD413 / ADP1)
Target Names
rplP
Target Protein Sequence
MLQPKRTKFR KVQKGRNTGL AHRGSTVSFG SIAIKATERG RMTARQIEAA RRTISRRIKR GGKIFIRVFP DKPITEKPLE VRMGNGKGNV EYWVCEIKPG KILYEIEGVN DELATQAFKL AAAKLPFKTT IVTRTVM
Uniprot No.

Target Background

Function
This protein binds to 23S rRNA and interacts with the A and potentially P sites of tRNAs.
Database Links
Protein Families
Universal ribosomal protein uL16 family

Q&A

What is the functional significance of 50S ribosomal protein L16 in Acinetobacter species?

The 50S ribosomal protein L16 (rplP) is a critical component of the large ribosomal subunit in Acinetobacter species. It plays essential roles in ribosomal assembly, stability, and protein synthesis functionality. In Acinetobacter, rplP contributes to the peptidyltransferase center formation, which is crucial for the catalytic activity of the ribosome during protein synthesis. Understanding this protein is particularly important given that Acinetobacter species, especially A. baumannii, are known for their multidrug resistance mechanisms and pathogenicity .

Methodologically, researchers can investigate rplP function through:

  • Genetic knockout studies with complementation assays

  • Site-directed mutagenesis targeting conserved residues

  • Ribosome profiling to assess translation efficiency

  • Structural studies using cryo-electron microscopy

How can researchers accurately identify and characterize rplP genes across Acinetobacter strains?

Identification and characterization of rplP genes across Acinetobacter strains require a combination of genomic and molecular approaches. PCR amplification using specific primers can effectively detect the gene in various isolates. For instance, researchers can adapt approaches similar to those used for 16S rRNA amplification in Acinetobacter species .

For thorough characterization:

  • Design degenerate primers targeting conserved regions of rplP based on alignments of known sequences

  • Perform PCR amplification followed by sequencing verification

  • Conduct multiple sequence alignment to identify conserved and variable regions

  • Analyze phylogenetic relationships to determine evolutionary patterns

This methodological approach can be particularly valuable when investigating Acinetobacter species with variable antibiotic resistance profiles, as observed in multidrug-resistant clinical isolates .

What molecular techniques provide the most reliable results for studying rplP expression in different Acinetobacter growth conditions?

When studying rplP expression across varying growth conditions in Acinetobacter species, researchers should employ multiple complementary techniques to ensure robust results:

TechniqueApplicationAdvantagesLimitations
RT-qPCRmRNA quantificationHigh sensitivity, relative quantificationRequires stable reference genes
Western BlottingProtein level detectionDirect protein measurementRequires specific antibodies
RNA-SeqTranscriptome-wide expressionComprehensive view, identifies co-regulated genesComputationally intensive analysis
Ribosome ProfilingTranslation efficiencyMeasures actual translationTechnically demanding
Proteomics (LC-MS/MS)Protein abundance and modificationsIdentifies post-translational modificationsExpensive, complex sample preparation

For optimal results, researchers should normalize expression data against multiple housekeeping genes and validate findings using at least two independent methods. This approach is particularly important when studying Acinetobacter under antibiotic stress conditions that might affect global translation machinery .

How do mutations in rplP contribute to antibiotic resistance mechanisms in Acinetobacter baumannii?

Mutations in the rplP gene can significantly contribute to antibiotic resistance in A. baumannii through several mechanisms. Ribosomal proteins, including L16, are targets for various antibiotics that inhibit protein synthesis. Specific mutations in rplP may alter the binding sites for these antibiotics, reducing their efficacy.

The research methodology to investigate this relationship includes:

  • Whole genome sequencing of resistant isolates to identify rplP mutations

  • Site-directed mutagenesis to introduce specific mutations

  • Minimum inhibitory concentration (MIC) determination to assess resistance levels

  • Structural modeling to predict how mutations affect antibiotic binding

  • In vitro translation assays to directly measure the impact on protein synthesis

Studies on multidrug-resistant A. baumannii have demonstrated that numerous resistance genes can coexist within a single isolate, creating complex resistance profiles . When investigating rplP mutations, researchers should consider this genetic complexity and potential interactions between different resistance mechanisms.

What structural features of recombinant Acinetobacter rplP make it challenging to express and purify for crystallographic studies?

Expression and purification of recombinant Acinetobacter rplP for structural studies present several challenges related to its intrinsic properties:

ChallengeCauseMethodological Solution
Protein aggregationHydrophobic regions that interact with rRNA/proteinsUse solubility tags (MBP, SUMO); optimize buffer conditions
Low expression yieldCodon bias between Acinetobacter and expression hostCodon optimization; use specialized expression strains
Structural instabilityAbsence of binding partners from 50S subunitCo-expression with interacting partners; addition of stabilizing agents
Improper foldingChaperone dependency in native contextExpression at lower temperatures; co-expression with chaperones
Toxicity to host cellsInterference with host translation machineryUse inducible expression systems; tightly controlled promoters

To overcome these challenges, researchers should:

  • Screen multiple expression systems (E. coli, yeast, insect cells)

  • Optimize induction conditions (temperature, inducer concentration, duration)

  • Test various purification strategies (affinity, ion-exchange, size-exclusion chromatography)

  • Consider protein engineering approaches to improve stability

These methodological considerations are particularly important given the significant sequence variations observed between different Acinetobacter strains, as has been documented in genomic surveillance studies .

How can cryo-electron microscopy approaches be optimized to study the role of rplP in Acinetobacter ribosome assembly?

Cryo-electron microscopy (cryo-EM) offers powerful capabilities for studying ribosome assembly and the specific role of rplP in Acinetobacter species. Optimizing cryo-EM approaches involves several methodological considerations:

  • Sample Preparation Optimization:

    • Isolate ribosomes at different assembly stages to capture intermediates

    • Use rplP depletion strains to examine assembly defects

    • Apply gradient purification to separate assembly intermediates

    • Optimize buffer conditions to maintain native conformations

  • Data Collection Strategies:

    • Implement time-resolved cryo-EM to capture dynamic assembly processes

    • Use direct electron detectors with high detective quantum efficiency

    • Apply energy filters to improve contrast

    • Collect tilt series to address preferred orientation issues

  • Image Processing Workflow:

    • Employ 3D classification to identify assembly intermediates

    • Use focused classification on the rplP binding region

    • Implement multi-body refinement to analyze flexible regions

    • Apply symmetry-relaxed reconstruction for asymmetric intermediates

  • Validation and Interpretation:

    • Correlate structural findings with biochemical assembly assays

    • Perform cross-linking mass spectrometry to validate protein-protein interactions

    • Use genetic approaches to verify the functional significance of structural findings

This methodological framework provides a comprehensive approach to visualizing and understanding how rplP contributes to ribosome assembly in Acinetobacter, which may have implications for understanding antibiotic resistance mechanisms .

What expression systems yield optimal results for producing functional recombinant Acinetobacter rplP protein?

Selecting the appropriate expression system for recombinant Acinetobacter rplP requires careful consideration of protein functionality and yield requirements:

Expression SystemAdvantagesDisadvantagesBest Applications
E. coli BL21(DE3)High yield, simple protocolsPotential inclusion body formationInitial screening, structural studies
E. coli RosettaAddresses codon bias issuesHigher costExpression of proteins with rare codons
E. coli ArcticExpressBetter folding at low temperaturesSlower growth, lower yieldsProteins prone to misfolding
Yeast (P. pastoris)Post-translational modificationsLonger development timeFunctional studies requiring modifications
Insect cell (Sf9)Complex folding supportExpensive, time-consumingInteraction studies with ribosomal partners
Cell-free systemsAvoids toxicity issuesLower yield, expensiveRapid screening, toxic proteins

Methodological recommendations:

  • Begin with a parallel screening approach using multiple expression systems

  • Test various fusion tags (His, GST, MBP, SUMO) for improved solubility

  • Optimize induction parameters (temperature, inducer concentration, time)

  • Evaluate functionality using in vitro translation assays

  • Confirm structural integrity through circular dichroism or limited proteolysis

When designing expression constructs, consider that Acinetobacter species often have unique codon usage patterns that may affect heterologous expression efficiency, as observed in genomic analyses of various Acinetobacter strains .

How should researchers design experiments to investigate rplP interactions with antibiotics in multidrug-resistant Acinetobacter strains?

Investigating rplP interactions with antibiotics in multidrug-resistant Acinetobacter requires a multi-faceted experimental approach:

  • Binding Studies:

    • Surface plasmon resonance (SPR) to determine binding kinetics

    • Isothermal titration calorimetry (ITC) to measure thermodynamic parameters

    • Fluorescence-based assays for high-throughput screening

    • Hydrogen-deuterium exchange mass spectrometry to map binding interfaces

  • Functional Assays:

    • In vitro translation systems using purified components

    • Toe-printing assays to assess ribosomal positioning

    • Ribosome profiling to measure translation efficiency in vivo

    • Growth inhibition assays with antibiotic concentration gradients

  • Structural Approaches:

    • Cryo-EM of ribosome-antibiotic complexes

    • X-ray crystallography of rplP domains with bound antibiotics

    • Molecular dynamics simulations to predict binding site flexibility

    • Site-directed mutagenesis to validate key interaction residues

  • Resistance Mechanism Investigation:

    • Comparative studies between sensitive and resistant strains

    • Directed evolution experiments to identify resistance-conferring mutations

    • Gene replacement studies to confirm causative mutations

    • Transcriptomics to identify compensatory mechanisms

These methodological approaches should consider the complex genetic background of multidrug-resistant Acinetobacter strains, which often carry multiple resistance determinants. Studies have shown that clinical isolates can harbor more than eight identified resistance determinants, creating complex resistance profiles .

What controls are essential when evaluating the impact of rplP mutations on Acinetobacter virulence and fitness?

Control TypePurposeImplementation
Wild-type strainEstablish baseline phenotypeUse isogenic parent strain
Complemented mutantVerify phenotype is due to rplP mutationExpress wild-type rplP from plasmid in mutant
Unrelated gene mutantControl for general effects of genetic manipulationCreate mutation in non-ribosomal gene
Growth controlsAccount for growth rate differencesNormalize data to growth parameters
Media controlsControl for environmental effectsTest multiple media conditions
In vivo controlsAccount for host factorsInclude mock-infected animals/cells
Technical controlsControl for experimental variationInclude technical replicates
Biological controlsAccount for strain-specific effectsTest multiple clinical isolates

Essential methodological approaches:

  • Generate clean deletion mutants using allelic exchange to avoid polar effects

  • Confirm mutations by whole genome sequencing to identify potential compensatory mutations

  • Measure fitness parameters (growth rate, competition assays) under multiple conditions

  • Assess virulence using multiple models (cell culture, invertebrate, vertebrate)

  • Quantify ribosome function using polysome profiling and translation efficiency assays

These controls are particularly important considering that Acinetobacter baumannii carries multiple virulence factors that contribute to pathogenesis, as highlighted in microbiological studies .

How can researchers reconcile contradictory findings about rplP function across different Acinetobacter species?

Contradictory findings regarding rplP function across Acinetobacter species are not uncommon and require systematic approaches to reconcile:

  • Standardization of Experimental Conditions:

    • Establish consistent growth conditions, media compositions, and physiological states

    • Standardize protein expression and purification protocols

    • Use identical assay systems across different species

    • Implement unified data collection and analysis pipelines

  • Comparative Genomics Approach:

    • Conduct comprehensive sequence alignments of rplP across species

    • Identify species-specific amino acid substitutions that might explain functional differences

    • Analyze genomic context and operon structure around rplP

    • Examine evolutionary relationships through phylogenetic analysis

  • Integrative Data Analysis:

    • Perform meta-analysis of published results with standardized effect size calculations

    • Use Bayesian statistical approaches to integrate heterogeneous datasets

    • Apply systems biology modeling to contextualize rplP within the broader cellular network

    • Develop predictive models that account for species-specific variations

  • Experimental Validation:

    • Design chimeric rplP proteins to identify functionally divergent domains

    • Perform cross-species complementation studies

    • Conduct site-directed mutagenesis to convert residues between species

    • Use heterologous expression systems to assess functional conservation

These methodological approaches acknowledge the significant genetic diversity within Acinetobacter species. Studies have demonstrated that even within the same species, substantial phylogenetic diversity exists, as observed in genomic surveillance studies of Acinetobacter baumannii .

What bioinformatic approaches are most effective for predicting the impact of novel rplP mutations on antibiotic resistance?

Predicting the impact of novel rplP mutations on antibiotic resistance requires sophisticated bioinformatic approaches:

Bioinformatic ApproachApplicationAdvantagesMethodological Considerations
Homology ModelingPredict structural changesFast, uses known structuresAccuracy depends on template similarity
Molecular DynamicsSimulate antibiotic bindingCaptures dynamic interactionsComputationally intensive
Machine LearningPredict resistance phenotypesCan integrate diverse data typesRequires large training datasets
Genome-Wide AssociationIdentify resistance-associated SNPsDiscovers novel associationsNeeds many sequenced isolates
Evolutionary AnalysisIdentify selection pressureDetects adaptive mutationsRequires diverse temporal samples
Network AnalysisPredict epistatic interactionsMaps compensatory mutationsComplex to implement

Recommended methodological workflow:

  • Start with sequence conservation analysis to identify potentially important residues

  • Perform structural prediction using homology modeling based on available ribosome structures

  • Conduct molecular docking simulations with relevant antibiotics

  • Validate predictions with experimental MIC determinations

  • Iterate the model using measured resistance phenotypes

This systematic approach can help predict resistance mechanisms, which is particularly valuable given the complex resistance profiles observed in multidrug-resistant Acinetobacter isolates . Studies have shown that Acinetobacter can harbor multiple resistance determinants that may interact in complex ways to produce the final resistance phenotype.

How should researchers interpret changes in rplP expression in the context of Acinetobacter adaptation to antibiotic stress?

Interpreting changes in rplP expression during Acinetobacter adaptation to antibiotic stress requires a nuanced analytical framework:

  • Temporal Expression Analysis:

    • Measure expression at multiple time points following antibiotic exposure

    • Distinguish between immediate responses and adaptive changes

    • Determine if expression changes are sustained after antibiotic removal

    • Compare expression patterns across different antibiotic classes

  • Contextual Interpretation:

    • Analyze rplP expression in relation to other ribosomal proteins

    • Assess coordinated responses of translation-related genes

    • Examine expression in context of global stress responses

    • Consider potential regulatory network effects

  • Functional Consequences Assessment:

    • Correlate expression changes with translation efficiency

    • Measure impact on growth rate and fitness

    • Determine effects on antibiotic susceptibility

    • Assess influence on virulence factor expression

  • Statistical and Analytical Approaches:

    • Apply time-series analysis methods to capture expression dynamics

    • Use principal component analysis to identify major response patterns

    • Implement network analysis to identify co-regulated genes

    • Develop predictive models of adaptation based on expression profiles

This comprehensive analytical framework helps researchers distinguish between adaptive responses and non-specific stress reactions. Studies on carbapenem-resistant Acinetobacter baumannii have shown that adaptation to antibiotics involves complex genomic changes that can affect multiple cellular systems .

How can CRISPR-Cas9 technology be optimized for studying rplP function in multidrug-resistant Acinetobacter strains?

CRISPR-Cas9 technology offers powerful capabilities for studying rplP function in multidrug-resistant Acinetobacter, but requires optimization:

  • Delivery System Optimization:

    • Develop efficient electroporation protocols specific for Acinetobacter

    • Optimize conjugation-based transfer methods for clinical isolates

    • Design specialized delivery vectors with Acinetobacter-specific origins of replication

    • Implement transient expression systems to minimize off-target effects

  • Guide RNA Design Strategies:

    • Create species-specific algorithms for gRNA design in Acinetobacter

    • Target conserved regions to improve editing efficiency

    • Develop multiplexed gRNA systems for simultaneous editing of rplP and related genes

    • Implement machine learning approaches to predict off-target effects

  • Editing Strategy Selection:

    • For essential genes like rplP, use inducible CRISPR interference (CRISPRi) systems

    • Implement base editing for precise nucleotide substitutions without double-strand breaks

    • Design conditional knockout systems for temporal control of gene expression

    • Create scarless editing protocols to avoid polar effects on downstream genes

  • Validation and Phenotypic Analysis:

    • Implement whole genome sequencing to verify edits and detect off-target effects

    • Develop high-throughput screening methods to assess antibiotic susceptibility

    • Utilize ribosome profiling to directly measure functional impacts on translation

    • Apply comparative proteomics to assess global effects of rplP modifications

These methodological considerations are particularly important given the genetic complexity of multidrug-resistant Acinetobacter strains, which often harbor multiple resistance mechanisms requiring precise genetic manipulation approaches .

What are the most promising approaches for targeting rplP as a novel antibiotic development strategy against Acinetobacter?

Targeting rplP for novel antibiotic development against Acinetobacter requires innovative approaches:

ApproachMechanismAdvantagesMethodological Considerations
Structure-Based Drug DesignRational design based on rplP structureHighly specificRequires high-resolution structures
Fragment-Based ScreeningIdentify small molecule bindersDiscovers novel scaffoldsNeeds specialized screening assays
Peptide MimeticsMimic natural rplP interacting partnersHigh specificityDelivery challenges
Antisense OligonucleotidesTarget rplP mRNASequence-specificCellular uptake limitations
Ribosome Assembly InhibitorsBlock rplP incorporationNovel mechanismComplex screening requirements
Allosteric ModulatorsAlter rplP function without direct bindingOvercome resistanceDifficult to design rationally

Recommended methodological workflow:

  • Perform comparative structural analysis of rplP across bacterial species to identify Acinetobacter-specific features

  • Develop high-throughput screening assays specific for rplP function

  • Conduct virtual screening followed by experimental validation

  • Assess specificity against human ribosomal proteins to minimize toxicity

  • Evaluate activity against diverse clinical isolates

  • Test for resistance development through serial passage experiments

This targeted approach could address the urgent need for new antibiotics against multidrug-resistant Acinetobacter strains. Studies have shown that A. baumannii can develop resistance to multiple antibiotic classes through various mechanisms , highlighting the need for novel therapeutic strategies with distinct mechanisms of action.

How does the interaction between rplP and other ribosomal components change in antibiotic-resistant Acinetobacter compared to susceptible strains?

The interaction dynamics between rplP and other ribosomal components in antibiotic-resistant versus susceptible Acinetobacter can be investigated through several methodological approaches:

  • Structural Comparative Analysis:

    • Perform cryo-EM of ribosomes from resistant and susceptible strains

    • Conduct hydrogen-deuterium exchange mass spectrometry to map interaction interfaces

    • Use chemical cross-linking followed by mass spectrometry to identify proximal proteins

    • Apply single-molecule FRET to measure dynamic interactions

  • Interaction Network Mapping:

    • Implement ribosome profiling to assess translation complex formation

    • Perform co-immunoprecipitation studies with tagged rplP variants

    • Utilize bacterial two-hybrid systems to screen for altered interactions

    • Apply proteome-wide thermal shift assays to detect stability changes

  • Functional Assessment:

    • Develop reconstituted in vitro translation systems with defined components

    • Measure kinetics of ribosome assembly with purified components

    • Assess antibiotic binding kinetics in reconstituted systems

    • Quantify translational fidelity using reporter systems

  • Computational Approaches:

    • Perform molecular dynamics simulations of ribosomal complexes

    • Use network analysis to identify altered interaction patterns

    • Apply machine learning to predict functional consequences of altered interactions

    • Develop mathematical models of ribosome assembly kinetics

These methodological approaches can provide insights into how antibiotic resistance mutations in rplP affect its interactions with other ribosomal components, potentially revealing new therapeutic targets. Studies on multidrug-resistant Acinetobacter have demonstrated that resistance can involve complex mechanisms affecting multiple cellular components .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.